U.S. Bioanalytical Testing Services Market (2025 - 2030) Size, Share & Trends Analysis Report By Molecule (Small Molecule, Large Molecule), By Test, By Workflow, By End-use (Pharma & BioPharma Companies, CDMO, CRO), And Segment Forecasts

Market Segmentation

U.S. Bioanalytical Testing Services Molecule Outlook (Revenue, USD Million, 2018 - 2030)
- Small Molecule
- Large Molecule
  - LC-MS Studies
  - Immunoassays
    - Pharmacokinetics (PK)
    - ADA Assay
    - Other immunoassays
  - Other Large Molecule Tests
U.S. Bioanalytical Testing Services Test Outlook (Revenue, USD Million, 2018 - 2030)
- ADME
  - In-vivo
  - In-vitro
- Pharmacokinetics (PK)
- Pharmacodynamics (PD)
- Bioavailability
- Bioequivalence
- Biomarker Testing
- Cell-based Assay
- Virology Testing
- Other Tests
U.S. Bioanalytical Testing Services Workflow Outlook (Revenue, USD Million, 2018 - 2030)
- Sample Collection and Preparation
  - Sample Collection, Handling and Storage
  - Protein Precipitation
  - Liquid-Liquid Extraction
  - Solid Phase Extraction
  - Others
- Method Development and Validation
- Sample Analysis
  - Hyphenated Technique
  - Chromatographic Technique
  - Electrophoresis
  - Ligand Binding Assay
  - Mass Spectrometry
  - Spectroscopic Techniques
    - Nuclear Magnetic Resonance (NMR)
    - Others
  - Genomic and Molecular Techniques
    - Polymerase Chain Reaction (PCR)
    - Next-Generation Sequencing (NGS)
    - Others
- Other Processes
U.S. Bioanalytical Testing Services End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Pharma & BioPharma Companies
- CDMO
- CRO
- Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments